Ribeiro José A, Fernandes Paula M V, Pereira Carlos M, Silva F
Faculdade de Ciências da Universidade do Porto, Departamento de Química e Bioquímica, Centro de Investigação em Química (CIQUP)Rua do Campo Alegre 687Porto4169-007Portugal.
Faculdade de Ciências da Universidade do Porto, Departamento de Química e Bioquímica, Centro de Investigação em Química (CIQUP)Rua do Campo Alegre 687Porto4169-007Portugal.
Talanta. 2016 Nov 1;160:653-679. doi: 10.1016/j.talanta.2016.06.066. Epub 2016 Jul 1.
This work describes the state of the art of electrochemical devices for the detection of an important class of neurotransmitters: the catecholamines. This class of biogenic amines includes dopamine, noradrenaline (also called norepinephrine) and adrenaline (also called epinephrine). Researchers have focused on the role of catecholamine molecules within the human body because they are involved in many important biological functions and are commonly associated with several diseases, such as Alzheimer's and Parkinson. Furthermore, the release of catecholamines as a consequence of induced stimulus is an important indicator of reward-related behaviors, such as food, drink, sex and drug addiction. Thus, the development of simple, fast and sensitive electroanalytical methodologies for the determination of catecholamines is currently needed in clinical and biomedical fields, as they have the potential to serve as clinically relevant biomarkers for specific disease states or to monitor treatment efficacy. Currently, three main strategies have used by researchers to detect catecholamine molecules, namely: the use electrochemical materials in combination with, for example, HPLC or FIA, the incorporation of new materials/layers on the sensor surfaces (Tables 1-7) and in vivo detection, manly by using FSCV at CFMEs (Section 10). The developed methodologies were able not only to accurately detect catecholamines at relevant concentration levels, but to do so in the presence of co-existing interferences in samples detected (ascorbate, for example). This review examines the progress made in electrochemical sensors for the selective detection of catecholamines in the last 15 years, with special focus on highly innovative features introduced by nanotechnology. As the literature in rather extensive, we try to simplify this work by summarizing and grouping electrochemical sensors according to the manner their substrates were chemically modified. We also discuss the current and future of electrochemical sensors for catecholamines in terms of the analytical performance of the devices and emerging applications.
这项工作描述了用于检测一类重要神经递质——儿茶酚胺的电化学装置的技术现状。这类生物胺包括多巴胺、去甲肾上腺素(也称为正肾上腺素)和肾上腺素(也称为肾上腺素)。研究人员一直关注儿茶酚胺分子在人体内的作用,因为它们参与许多重要的生物学功能,并且通常与多种疾病相关,如阿尔茨海默病和帕金森病。此外,由于诱导刺激而释放的儿茶酚胺是与奖励相关行为(如食物、饮料、性行为和药物成瘾)的重要指标。因此,临床和生物医学领域目前需要开发简单、快速且灵敏的电分析方法来测定儿茶酚胺,因为它们有可能作为特定疾病状态的临床相关生物标志物或监测治疗效果。目前,研究人员使用了三种主要策略来检测儿茶酚胺分子,即:将电化学材料与例如高效液相色谱(HPLC)或流动注射分析(FIA)结合使用;在传感器表面引入新材料/层(表1 - 7);以及体内检测,主要是在碳纤维微电极(CFMEs)上使用快速扫描循环伏安法(FSCV)(第10节)。所开发的方法不仅能够在相关浓度水平下准确检测儿茶酚胺,而且能够在检测样品中存在共存干扰物(例如抗坏血酸)的情况下做到这一点。本综述考察了过去15年中用于选择性检测儿茶酚胺的电化学传感器所取得的进展,特别关注纳米技术引入的高度创新特性。由于文献相当广泛,我们试图通过根据其底物的化学修饰方式对电化学传感器进行总结和分组来简化这项工作。我们还从装置的分析性能和新兴应用方面讨论了儿茶酚胺电化学传感器的现状和未来。